XML 191 R174.htm IDEA: XBRL DOCUMENT
v3.22.1

Gains (losses) from operating activities in the statement of income, included according to their nature (Details) - USD ($) $ in Thousands | 12 Months Ended
--- | ---
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019
Statement [Line Items] |  |  |
Revenue | $ 2,862,315 | $ 1,817,191 | $ 1,943,655
Specialty plant nutrition [Member] |  |  |
Statement [Line Items] |  |  |
Revenue | 908,815 | 701,688 | 723,920
Iodine and derivatives [Member] |  |  |
Statement [Line Items] |  |  |
Revenue | 437,931 | 334,657 | 371,020
Lithium and Derivatives [Member] |  |  |
Statement [Line Items] |  |  |
Revenue | 936,121 | 383,373 | 505,714
Potassium [Member] |  |  |
Statement [Line Items] |  |  |
Revenue | 416,592 | 209,294 | 212,151
Industrial chemicals [Member] |  |  |
Statement [Line Items] |  |  |
Revenue | 132,011 | 160,608 | 94,875
Others [Member] |  |  |
Statement [Line Items] |  |  |
Revenue | 30,845 | 27,571 | 35,975
Chile [Member] |  |  |
Statement [Line Items] |  |  |
Revenue | 219,648 | 153,745 | 211,857
Chile [Member] | Specialty plant nutrition [Member] |  |  |
Statement [Line Items] |  |  |
Revenue | 136,523 | 100,353 | 109,975
Chile [Member] | Iodine and derivatives [Member] |  |  |
Statement [Line Items] |  |  |
Revenue | 1,538 | 1,234 | 1,064
Chile [Member] | Lithium and Derivatives [Member] |  |  |
Statement [Line Items] |  |  |
Revenue | 901 | 399 | 599
Chile [Member] | Potassium [Member] |  |  |
Statement [Line Items] |  |  |
Revenue | 50,573 | 23,963 | 27,371
Chile [Member] | Industrial chemicals [Member] |  |  |
Statement [Line Items] |  |  |
Revenue | 4,125 | 4,059 | 39,512
Chile [Member] | Others [Member] |  |  |
Statement [Line Items] |  |  |
Revenue | 25,988 | 23,737 | 33,336
Latin America and the Caribbean [Member] |  |  |
Statement [Line Items] |  |  |
Revenue | 326,287 | 159,990 | 161,928
Latin America and the Caribbean [Member] | Specialty plant nutrition [Member] |  |  |
Statement [Line Items] |  |  |
Revenue | 88,990 | 69,535 | 78,872
Latin America and the Caribbean [Member] | Iodine and derivatives [Member] |  |  |
Statement [Line Items] |  |  |
Revenue | 10,198 | 10,843 | 7,972
Latin America and the Caribbean [Member] | Lithium and Derivatives [Member] |  |  |
Statement [Line Items] |  |  |
Revenue | 4,905 | 1,597 | 3,593
Latin America and the Caribbean [Member] | Potassium [Member] |  |  |
Statement [Line Items] |  |  |
Revenue | 214,304 | 72,697 | 64,868
Latin America and the Caribbean [Member] | Industrial chemicals [Member] |  |  |
Statement [Line Items] |  |  |
Revenue | 7,367 | 4,951 | 6,354
Latin America and the Caribbean [Member] | Others [Member] |  |  |
Statement [Line Items] |  |  |
Revenue | 523 | 367 | 269
Europe |  |  |
Statement [Line Items] |  |  |
Revenue | 482,765 | 380,125 | 393,764
Europe | Specialty plant nutrition [Member] |  |  |
Statement [Line Items] |  |  |
Revenue | 179,744 | 145,896 | 149,992
Europe | Iodine and derivatives [Member] |  |  |
Statement [Line Items] |  |  |
Revenue | 173,329 | 142,161 | 123,525
Europe | Lithium and Derivatives [Member] |  |  |
Statement [Line Items] |  |  |
Revenue | 75,674 | 49,719 | 76,250
Europe | Potassium [Member] |  |  |
Statement [Line Items] |  |  |
Revenue | 33,948 | 30,029 | 27,973
Europe | Industrial chemicals [Member] |  |  |
Statement [Line Items] |  |  |
Revenue | 18,662 | 11,585 | 15,289
Europe | Others [Member] |  |  |
Statement [Line Items] |  |  |
Revenue | 1,408 | 735 | 735
North America |  |  |
Statement [Line Items] |  |  |
Revenue | 558,002 | 427,570 | 451,272
North America | Specialty plant nutrition [Member] |  |  |
Statement [Line Items] |  |  |
Revenue | 314,895 | 246,737 | 243,399
North America | Iodine and derivatives [Member] |  |  |
Statement [Line Items] |  |  |
Revenue | 102,746 | 90,292 | 90,070
North America | Lithium and Derivatives [Member] |  |  |
Statement [Line Items] |  |  |
Revenue | 50,349 | 25,558 | 45,810
North America | Potassium [Member] |  |  |
Statement [Line Items] |  |  |
Revenue | 57,682 | 39,432 | 43,312
North America | Industrial chemicals [Member] |  |  |
Statement [Line Items] |  |  |
Revenue | 29,860 | 23,963 | 27,798
North America | Others [Member] |  |  |
Statement [Line Items] |  |  |
Revenue | 2,470 | 1,588 | 883
Asia and others [Member] |  |  |
Statement [Line Items] |  |  |
Revenue | 1,275,613 | 695,761 | 724,834
Asia and others [Member] | Specialty plant nutrition [Member] |  |  |
Statement [Line Items] |  |  |
Revenue | 188,663 | 139,167 | 141,682
Asia and others [Member] | Iodine and derivatives [Member] |  |  |
Statement [Line Items] |  |  |
Revenue | 150,120 | 90,127 | 148,389
Asia and others [Member] | Lithium and Derivatives [Member] |  |  |
Statement [Line Items] |  |  |
Revenue | 804,292 | 306,100 | 379,462
Asia and others [Member] | Potassium [Member] |  |  |
Statement [Line Items] |  |  |
Revenue | 60,085 | 43,173 | 48,627
Asia and others [Member] | Industrial chemicals [Member] |  |  |
Statement [Line Items] |  |  |
Revenue | 71,997 | 116,050 | 5,922
Asia and others [Member] | Others [Member] |  |  |
Statement [Line Items] |  |  |
Revenue | $ 456 | $ 1,144 | $ 752

X
- Definition The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 8 -IssueDate 2021-01-01 -Paragraph 28 -Subparagraph a -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_28_a&doctype=Standard -URIDate 2021-03-24 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 8 -IssueDate 2021-01-01 -Paragraph 23 -Subparagraph a -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_23_a&doctype=Standard -URIDate 2021-03-24 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 8 -IssueDate 2021-01-01 -Paragraph 32 -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_32&doctype=Standard -URIDate 2021-03-24 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 8 -IssueDate 2021-01-01 -Paragraph 33 -Subparagraph a -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_33_a&doctype=Standard -URIDate 2021-03-24 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 8 -IssueDate 2021-01-01 -Paragraph 34 -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_34&doctype=Standard -URIDate 2021-03-24 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2021-01-01 -Paragraph 82 -Subparagraph a -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_82_a&doctype=Standard -URIDate 2021-03-24 Reference 7: http://www.xbrl.org/2003/role/exampleRef -Name IAS -Number 1 -IssueDate 2021-01-01 -Paragraph 103 -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_103&doctype=Standard -URIDate 2021-03-24 Reference 8: http://www.xbrl.org/2003/role/exampleRef -Name IAS -Number 1 -IssueDate 2021-01-01 -Paragraph 102 -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_102&doctype=Standard -URIDate 2021-03-24 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 5 -IssueDate 2021-01-01 -Paragraph 33 -Subparagraph b -Clause i -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2021-en-r&anchor=para_33_b_i&doctype=Standard -URIDate 2021-03-24 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 12 -IssueDate 2021-01-01 -Paragraph B12 -Subparagraph b -Clause v -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B12_b_v&doctype=Appendix&subtype=B -URIDate 2021-03-24 Reference 11: http://www.xbrl.org/2003/role/exampleRef -Name IFRS -Number 12 -IssueDate 2021-01-01 -Paragraph B10 -Subparagraph b -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B -URIDate 2021-03-24 + Details
Name: | ifrs-full_Revenue
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Statement + References No definition available. + Details
Name: | sqm_StatementLineItems
Namespace Prefix: | sqm_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | ifrs-full_ProductsAndServicesAxis=sqm_SpecialtyPlantNutritionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ProductsAndServicesAxis=sqm_IodineAndDerivativesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ProductsAndServicesAxis=sqm_LithiumAndDerivativesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ProductsAndServicesAxis=sqm_PotassiumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ProductsAndServicesAxis=sqm_IndustrialChemicalsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ProductsAndServicesAxis=sqm_OthersMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_GeographicalAreasAxis=sqm_ChileCountryMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_GeographicalAreasAxis=sqm_LatinAmericaAndCaribbeanMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_GeographicalAreasAxis=sqm_AjayEuropeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_GeographicalAreasAxis=sqm_AjayNorthAmericaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_GeographicalAreasAxis=sqm_AsiaAndOthersMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |